NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Thinking About Buying Stock Or Options In Wells Fargo, Taiwan Semiconductor Manufacturing Or Rite Aid?

Published 12/04/2022, 14:06
Updated 12/04/2022, 14:40
© Reuters.  Thinking About Buying Stock Or Options In Wells Fargo, Taiwan Semiconductor Manufacturing Or Rite Aid?
WFC
-
US90274J5618=UBSS
-
TSM
-
TGTB34
-

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders.

Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers, and following industry trends.

Here are the latest analyst rating updates for Wells Fargo & Co (NYSE: NYSE:WFC), Taiwan Semiconductor Mfg. Co. Ltd. (NYSE: TSM) and Rite Aid Corporation (NYSE: RAD):

The latest price target for Wells Fargo was reported by Citigroup (NYSE:C) on April 11. The analyst firm set a price target of $56.00, a possible 13.53% upside. Seventeen analyst firms have reported ratings in the last year.

Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets.

Traders and investors will be watching for Wells Fargo’s first-quarter earnings report, confirmed for Thursday before the market opens. Wells Fargo is expected to report EPS of 80 cents on revenue of $17.79 billion.

The latest price target for Taiwan Semiconductor was reported by Atlantic Equities on Jan. 13. The analyst firm set a price target of $170.00, a possible 74.27% upside. Five analyst firms have reported ratings in the last year.

Taiwan Semiconductor Manufacturing Company is the world's largest dedicated chip foundry.

Traders and investors will be watching for Taiwan Semiconductor’s first-quarter earnings report, confirmed for Thursday before the market opens.

Also Read: Why This Nvidia, Qualcomm (NASDAQ:QCOM) Analyst Is Lowering Price Targets For These Chip Stocks

The latest price target for Rite Aid was reported by Deutsche Bank (DE:DBKGn) on April 7. The analyst firm set a price target of $1.00, a possible -86.60% downside. 2 analyst firms have reported ratings in the last year.

Rite Aid is a large retail drugstore chain in the United States.

Traders and investors will be watching for Rite Aid’s fourth-quarter earnings report, confirmed for Thursday before the market opens. Rite Aid is expected to report an EPS loss of 56 cents on revenue of $5.95 billion.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.